Chronopin: upcoming release dates, events and other important dates

S1101 is a 200 MW battery storage interconnection request in St. Francis, AR. The grid operator lists its queue status as Active. The requested in-service date is 2028-01-20; this is a planning date.

Greatest eclipse falls at 15:07:46 UT on 2028-01-26, where the annular phase lasts 10 minutes 27 seconds on a path 323.0 km wide; the longest annularity anywhere on the track is 10m30.6s. The path of annularity crosses Ecuador, Peru, Brazil, Suriname, Spain and Portugal, and a partial eclipse is visible from eastern North America, C. & South America, western Europe and northwestern Africa.

Construction is underway on 112 affordable apartments: 56 for adults aged 55+ and 56 for families, at 30%–60% AMI. Eighteen senior apartments have project-based vouchers. Property information reviewed October 10, 2026.

Urban Grid development of the Spring Valley Clean Solar Center Phase 2 in Colbert County, Alabama. Supplying 200 MWac of utility-scale solar generation, the facility interfaces with the Tennessee Valley Authority (TVA) bulk transmission system to accelerate decarbonization across northern Alabama.

ERCOT September 2026 GIS lists 18-Bravo BESS request 28INR0327 in Hunt County at 407 MW, with Scout Energy Management, LLC as applicant and February 1, 2028 projected COD. Screening is complete and full study started; no interconnection agreement is reported.

The NFL championship game for the 2027 season is played at Mercedes-Benz Stadium in Atlanta, the city's fourth Super Bowl and the second at this venue after Super Bowl LIII in 2019. CBS has the national broadcast.

Novo Nordisk's phase 3 trial of Cagrisema in obesity reaches primary completion, the point at which the last participant's primary outcome is measured. The trial enrolled 2,500 participants. This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight. The purpose of the study is to find out how safe and effective CagriSema is for body weight loss in these participants. Participants will receive either CagriSema or semaglutide, and which treatment participants receive is decided by chance. CagriSema is a new study medicine being tested, while semaglutide is a medicine that doctors can already prescribe.

Separate construction cost, IT power, floor area and an opening date for this building or phase have not been verified. Published campus figures do not establish independent component figures.

ERCOT lists Aldrin 138 BESS request 25INR0421, Aldrin Energy Storage LLC, 207 MW in Brazoria County, targeting March 1, 2028 with studies complete and IA reported. Vesper’s current Aldrin site describes a broader 550 MW / 1,100 MWh proposal in active development, as soon as early 2028.

Sanofi's phase 3 trial of MenQuadfi in meningococcal infection reaches primary completion, the point at which the last participant's primary outcome is measured. The trial enrolled 4,568 participants. The purpose of this study is to describe the safety and immunogenicity of MenACYW conjugate vaccine compared with locally-licensed meningococcal vaccines in healthy infants and toddlers in China. Study details include: * Study duration (including 6-month safety follow-up after the last dose): * Cohort I (Groups 1 and 2): approximately 211 or 271 days (approximately 7 or 9 months) * Cohort II (Groups 3 and 4): up to 18 months * Cohort III (Groups 5 and 6): up to 21 months * Cohort III (Group 7): approximately 16 months * Vaccination Visits Period: * Cohort I (Groups 1 and 2): a 2-dose vaccination at V01 (D01) and V02 (D31) or V03 (D91). Two blood samples are collected pre-vaccination (D01) and 30 days post the 2nd dose of vaccination (D61 or D121).